Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by ALCON PHARMS LTD
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
018634
BETADINE
New Drug Application
Approval
New formulation
(S) Standard review drug
019992
CILOXAN
New Drug Application
Approval
New formulation
(S) Standard review drug
020369
CILOXAN
New Drug Application
Approval
New formulation
(S) Standard review drug
020805
CIPRO HC
New Drug Application
Approval
New formulation
(S) Standard review drug
020816
AZOPT
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021114
BETAXON
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(P) Priority review drug
021257
TRAVATAN
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
021537
CIPRODEX
New Drug Application
Approval
New formulation
(S) Standard review drug
021545
PATADAY
New Drug Application
Approval
New formulation
(S) Standard review drug
021598
VIGAMOX
New Drug Application
Approval
New formulation
(S) Standard review drug
021764
QOLIANA
New Drug Application
Approval
New manufacturer
(S) Standard review drug
021861
PATANASE
New Drug Application
Approval
New formulation
(S) Standard review drug
021862
NEVANAC
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
021980
FLUORESCITE
New Drug Application
Approval
New manufacturer
(P) Priority review drug
021994
TRAVATAN Z
New Drug Application
Approval
New manufacturer
(S) Standard review drug
022193
NAVSTEL
New Drug Application
Approval
New formulation
(S) Standard review drug
022212
DUREZOL
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
022428
MOXEZA
New Drug Application
Approval
New formulation
(S) Standard review drug
050818
TOBRADEX ST
New Drug Application
Approval
New formulation
(S) Standard review drug
062423
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Abbreviated New Drug Application
Approval
062488
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Abbreviated New Drug Application
Approval
062523
GENTAMICIN SULFATE
Abbreviated New Drug Application
Approval
062714
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
Abbreviated New Drug Application
Approval
062721
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
Abbreviated New Drug Application
Approval
062874
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Abbreviated New Drug Application
Approval
063176
TOBRAMYCIN
Abbreviated New Drug Application
Approval
073630
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
Abbreviated New Drug Application
Approval
074311
TRIFLURIDINE
Abbreviated New Drug Application
Approval
076231
OFLOXACIN
Abbreviated New Drug Application
Approval
076254
BRIMONIDINE TARTRATE
Abbreviated New Drug Application
Approval
076583
KETOROLAC TROMETHAMINE
Abbreviated New Drug Application
Approval
077200
KETOTIFEN FUMARATE
Abbreviated New Drug Application
Approval
078031
DICLOFENAC SODIUM
Abbreviated New Drug Application
Approval
078222
OFLOXACIN
Abbreviated New Drug Application
Approval
078721
KETOROLAC TROMETHAMINE
Abbreviated New Drug Application
Approval
078981
DORZOLAMIDE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
081043
PREDNISOLONE SODIUM PHOSPHATE
Abbreviated New Drug Application
Approval
081044
PREDNISOLONE SODIUM PHOSPHATE
Abbreviated New Drug Application
Approval
088771
DEXAMETHASONE SODIUM PHOSPHATE
Abbreviated New Drug Application
Approval
089068
SULFACETAMIDE SODIUM
Abbreviated New Drug Application
Approval
089162
CYCLOPENTOLATE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089172
TROPICAMIDE
Abbreviated New Drug Application
Approval
089560
SULFACETAMIDE SODIUM
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval